CCN(C(C)C)C(C)C.[CH3:10][C:11]1([CH3:34])[N:15]([C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[C@@H:14]([CH2:23][CH2:24][C:25]([N:27]2[C@H:31]([CH3:32])[CH2:30][O:29][C:28]2=[O:33])=[O:26])[CH2:13][O:12]1.[C:35]([O:39][C:40](=[O:43])[CH:41]=[CH2:42])([CH3:38])([CH3:37])[CH3:36]>C(Cl)Cl.Cl[Ti](Cl)(Cl)Cl>[C:35]([O:39][C:40](=[O:43])[CH2:41][CH2:42][C@@H:24]([C:25]([N:27]1[C@H:31]([CH3:32])[CH2:30][O:29][C:28]1=[O:33])=[O:26])[CH2:23][C@H:14]1[CH2:13][O:12][C:11]([CH3:10])([CH3:34])[N:15]1[C:16]([O:18][C:19]([CH3:20])([CH3:21])[CH3:22])=[O:17])([CH3:38])([CH3:37])[CH3:36]At 0° C., 1.0M TiCl4 in CH2Cl2 solution (8.55 mL, 0.7 eq) was added to CH2Cl2 (100 mL) followed by the addition of 1.0M TiCl(Oi-Pr)3 in hexanes solution (4.28 mL, 0.35 eq) and stirred 5 min DIPEA (2.87 mL, 1.35 eq) was added and stirred 15 min. A solution of (S)-tert-butyl 2,2-dimethyl-4-(3-((R)-4-methyl-2-oxooxazolidin-3-yl)-3-oxopropyl)oxazolidine-3-carboxylate (5.28 g, 12.22 mmol) in CH2Cl2 (50 mL) was added. The reaction mixture was stirred 1 hr at 0° C. To the solution, t-butylacrylate (2.22 mL, 1.25 eq) was added and the mixture was left stirred over 48 hr with concomitant warming to rt. The mixture was concentrated, partitioned between EtOAc (300 mL) and 1% HCl solution (100 mL). The organic layer was washed with sat. NaHCO3 solution (60 mL), brine (60 mL), dried over Na2SO4. After filtration and concentration, the residue was purified by ISCO (120 g column, 0→35% EtOAc in Hexanes gradient) to afford 4.12 g (60%) (S)-tert-butyl 4-((R)-5-tert-butoxy-2-((R)-4-methyl-2-oxooxazolidine-3-carbonyl)-5-oxopentyl)-2,2-dimethyloxazolidine-3-carboxylate as a yellowish solid. MS ESI +ve m/z 583 (M+Na).
불러오는 중…